Construct: ORF TRCN0000465549
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF003316.1_s317c1
- Derived from:
- ccsbBroadEn_01854
- DNA Barcode:
- CCCTTAACTCAAGAATGGTATGTG
- Epitope Tag:
- V5
- Notes:
- No stop codon in insert
Originally Annotated References:
- Gene:
- MLLT10 (8028)
Vector Information:
- Vector Backbone:
- pLX_317
- Pol II Cassette 1:
- SV40-PuroR
- Pol II Cassette 2:
- EF1a-TRCN0000465549
- Selection Marker:
- PuroR
- Visible Reporter:
- n/a
- Epitope Tag:
- V5
Current transcripts matched by this ORF:
Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
---|---|---|---|---|---|---|---|---|
1 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | NM_001195627.1 | 100% | 100% | |
2 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | NM_001195628.1 | 56.6% | 47.6% | (many diffs) |
3 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | NM_001195630.1 | 56.6% | 47.6% | (many diffs) |
4 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | NM_001324296.1 | 56.6% | 47.6% | (many diffs) |
5 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | XM_024448206.1 | 17.5% | 14.7% | (many diffs) |
6 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | NM_004641.3 | 10.4% | 8.7% | (many diffs) |
7 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | XM_024448191.1 | 10.2% | 8.6% | (many diffs) |
8 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | XM_024448190.1 | 10.1% | 8.5% | (many diffs) |
9 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | NM_001195626.3 | 10% | 8.4% | (many diffs) |
10 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | XM_024448187.1 | 10% | 8.4% | (many diffs) |
11 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | XM_024448188.1 | 10% | 8.4% | (many diffs) |
12 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | XM_024448186.1 | 9.9% | 8.3% | (many diffs) |
13 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | XM_024448184.1 | 9.8% | 8.2% | (many diffs) |
14 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | XM_024448183.1 | 9.8% | 8.2% | (many diffs) |
15 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | XM_024448179.1 | 9.7% | 8.1% | (many diffs) |
16 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | XM_024448180.1 | 9.7% | 8.1% | (many diffs) |
17 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | XM_024448181.1 | 9.7% | 8.1% | (many diffs) |
18 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | XM_024448182.1 | 9.7% | 8.1% | (many diffs) |
19 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | XR_002957016.1 | 9.2% | (many diffs) | |
20 | human | 8028 | MLLT10 | MLLT10 histone lysine methy... | NR_136736.1 | 6.2% | (many diffs) | |
21 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | XM_006497391.3 | 14.9% | 12.6% | (many diffs) |
22 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | XM_006497387.3 | 11.9% | 9.2% | (many diffs) |
23 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | XM_006497383.3 | 10.8% | 8.9% | (many diffs) |
24 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | XM_006497376.3 | 10.3% | 7.9% | (many diffs) |
25 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | XM_017316073.1 | 10.3% | 8.6% | (many diffs) |
26 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | XM_006497382.3 | 10.1% | 8.5% | (many diffs) |
27 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | NM_001252560.1 | 9.9% | 8.4% | (many diffs) |
28 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | NM_010804.4 | 9.9% | 8.4% | (many diffs) |
29 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | XM_006497377.3 | 9.9% | 8.4% | (many diffs) |
30 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | XM_006497375.3 | 9.9% | 8.4% | (many diffs) |
31 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | XM_006497374.3 | 9.7% | 8.2% | (many diffs) |
32 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | XM_006497373.3 | 9.6% | 8.1% | (many diffs) |
33 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | XM_006497372.3 | 9.5% | 8% | (many diffs) |
34 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | XM_006497371.3 | 9.5% | 8% | (many diffs) |
35 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | XM_006497378.3 | 9.5% | 8% | (many diffs) |
36 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | XM_006497379.3 | 9.5% | 8% | (many diffs) |
37 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | XM_006497380.1 | 9.5% | 8% | (many diffs) |
38 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | XM_006497381.3 | 9.5% | 8% | (many diffs) |
39 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | XR_001781133.1 | 6.5% | (many diffs) | |
40 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | NR_045538.1 | 6.3% | (many diffs) | |
41 | mouse | 17354 | Mllt10 | myeloid/lymphoid or mixed-l... | NR_045539.1 | 6.1% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 66
- ORF end:
- 444
- ORF length:
- 378
- Sequence:
-
1 tcttccattt caggtgtcgt gaggctagca tcgattgatc aacaagtttg tacaaaaaag 61 ttggcatggt ctctagcgac cggcccgtgt cactggagga cgaggtctcc catagtatga 121 aggagatgat tggaggctgt tgcgtttgcT CAGACGAGAG AGGCTGGGCC GAGAACCCGC 181 TGGTTTATTG CGACGGGCAC GGCTGCAGCG TCGCGGTGCA TCAAGCTTGC TATGGCATTG 241 TTCAAGTACC CACTGGACCG TGGTTTTGCA GGAAATGTGA ATCTCAGGAG AGAGCAGCCA 301 GAGTGGCAGA GTCTCGCTCT GTTGCCCAGG CTAAAGTGCA GTGGTGTGAT CTCAGCCCAC 361 TGCAACCTCT GCTCCCCGGG TTCAAGCGAT TCTCCTGCCT CAGCCTCCCA AATGGTATGC 421 AATTCCTGTT GGTTAGCCTC ATCTGCCCAA CTTTCTTGTA CAAAGTGGTT GATATCGGTA 481 AGCCTATCCC TAACCCTCTC CTCGGTCTCG ATTCTACGTA GTAATGAACT AGTCCGTAAC 541 TTGAAAGTAT TTCGATTTCT TGGCTTTATA TATCTTGTGG AAAGGACGAC CCTTAACTCA 601 AGAATGGTAT GTGACGCGTT AAGTCgacaa tcaacctctg gattacaaaa tttgtgaaag 661 att